INQ Group AB Converts $5.43 Million Debt to Equity, Slashing Loan Balance
INQ Group AB converted $5.43 million in debt to equity, reducing its convertible loan to $1.55 million while increasing its total share count.
Company news
Every story explained in plain English, with the prices that matter beside it.
Keel Infrastructure Shares Slide as Analysts Highlight Pennsylvania Concentration Risk
Keel Infrastructure Corp. shares fell as analysts warned that over 88% of its projected 2030 energy capacity is concentrated in Pennsylvania.
Bavarian Nordic Raises 2026 Outlook on Strong US Rabies Vaccine Demand
Bavarian Nordic raised its 2026 revenue and margin guidance due to high demand for travel vaccines, boosting its projected profitability.
Avatar Medical Secures European Approval for 3D and VR Surgical Imaging Software
Avatar Medical has received European CE Mark approval for its 3D and virtual reality surgical planning software, opening up new commercial markets.
Company newsBullish
Reading International Schedules Virtual 2026 Annual Stockholder Meeting for December
Reading International, Inc. has scheduled its virtual 2026 annual meeting for December 3. Only Class B stockholders will have voting rights.
Intea Fastigheter AB Secures 15-Year Lease to Build Trollhättan Ambulance Station
Intea Fastigheter AB will build a SEK 50 million ambulance station in Trollhättan, securing a 15-year inflation-indexed lease with a public tenant.
Space Exploration Technologies Stock Eyes Weekly Gain on FCC Spectrum Plans
Shares of Space Exploration Technologies Corp. track weekly gains as the FCC proposes new spectrum auctions to boost satellite-to-phone services.
Cloudera and stc group Partner to Drive Digital Transformation in Kuwait and Bahrain
Cloudera and stc group have partnered to modernize digital infrastructure, cybersecurity, and smart city initiatives across Kuwait and Bahrain.
Company newsNeutral
Lululemon Overhauls Leadership Team in Push to Reverse Sales Decline
Lululemon Athletica has appointed new product and operations chiefs to reverse a revenue slump that has dragged its stock down over 55% this year.
Newron Pharmaceuticals FDA Clinical Hold Remains in Place Over Safety Concerns
Newron Pharmaceuticals reports that an FDA clinical hold on its ENIGMA-TRS 2 trial remains active as the regulator reviews safety data.
argenx SE Halts Phase 3 UNITY Trial of Efgartigimod in Sjogren's Disease
argenx SE is halting its Phase 3 UNITY trial of efgartigimod in Sjogren's disease after an interim analysis showed the drug was unlikely to succeed.
Addex Therapeutics Spin-Out Neurosterix Completes Phase 1 Trial for Schizophrenia Drug
Neurosterix completed a Phase 1 study of its schizophrenia candidate NTX-253, marking an early milestone for 20% owner Addex Therapeutics.
Galderma Reports Long-Term Three-Year Efficacy and Safety Data for Nemluvio
Galderma reported that Nemluvio maintained skin clearance and itch relief for up to three years in patients with atopic dermatitis and prurigo nodularis.
Prisma Properties Signs 10-Year Lease with Hemköp for Malmköping Store
Prisma Properties AB secured a 10-year lease with Hemköp in Malmköping, generating SEK 2.5 million in annual rent to boost its long-term income.
TGS Reports Lower Third-Quarter Multi-Client Investment and Vessel Utilization
TGS Dis Ticaret AS reported preliminary third-quarter multi-client investment of $63 million, while fourth-quarter vessel capacity is fully booked.
argenx SE Reports Positive Phase 2 Trials for Celiac Disease Drug FB102
argenx SE has announced positive Phase 2 clinical trial results for its celiac disease treatment FB102, clearing the way for Phase 3 studies.
Amazon Eliminates Fewer Than 1,000 Corporate Jobs in Stores Division
Amazon has eliminated fewer than 1,000 corporate roles in its Stores division to adjust after pandemic overhiring. Shares rose 1.42%.
The Bancorp Stock Pulls Back as Contracting Margins Offset Revenue Growth
The Bancorp stock fell 15.4% over six months due to a contracting net interest margin, despite its strong long-term revenue growth.
Broadcom in Early Talks to Arrange $50 Billion Financing for OpenAI Custom Chips
Broadcom is negotiating over $50 billion in debt financing to help OpenAI purchase jointly developed custom artificial intelligence chips.
Robinhood and Public Offer 3% Match to Poach Webull Customers Over China Ties Report
Robinhood and Public offer 3% incentives to Webull users after a House panel raised concerns about Webull's China ties, sending its stock down 19%.